Category: forbeschina

Four Elements Of Healthcare Industry Leadership: Forbes China Summit

“Healthcare can often be a very conservative industry because it’s an industry that deals with very long timetables. However, playing it too safe and too careful can leave you behind competitors,” Forbes Senior Editor Alex Knapp believes.

U.S.-China Collaboration Could Cut Development Time, Cost For New Cancer Treatments

The world’s current system for developing cancer drugs is unsustainable, Memorial Sloan Kettering oncologist Dr. Bob Li believes.

Harness Uncertainty To Overcome It In Today’s Business World: Forbes China Summit

In today’s uncertain times, business leaders should focus on what is certain in their environment as a key approach to success, University of Michigan Business Professor told a Forbes China gathering last week

Expanding International Clinical Trials For Cancer Saves Lives. Why Not Act Faster?

More people around the world will die from cancer than from Covid-19 this year

Tech, Healthcare Companies Lead New Forbes China Up-And-Comers List

China’s healthcare industry is getting a boost from the pandemic and longer term aging in China

How COVID-19 Hit Memorial Sloan Kettering, A Top U.S. Cancer Center

Philanthropy is helping to save lives, absorb costs and advance treatment

How Int’l Collaboration Is Helping To Win A War Greater Than The COVID-19 Pandemic

Cancer will kill newly three quarters of a million people worldwide this year.